Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II MERIT study of AXS-05 achieves primary and key secondary endpoints

Aug. 10, 2021

Gruenenthal divulges glucocorticoid receptor modulators

Aug. 10, 2021

New PIN1 inhibitors discovered at Pimedbio, DGMIF

Aug. 10, 2021

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent ATR kinase inhibitors

Aug. 10, 2021

Korea Institute of Science and Technology identifies TNK2/MAP4K2 inhibitors

Aug. 10, 2021

First patient dosed in phase Ib/II study of AVB-500 in pancreatic adenocarcinoma

Aug. 10, 2021

TRACON presents safety data review results for ENVASARC pivotal trial of envafolimab

Aug. 10, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Response rate shows potential of ficlatuzumab with chemotherapy in treating AML

Aug. 9, 2021

AstraZeneca starts phase II SOLANO study of AZD-8233

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...